导航Gram-阴性细菌中的诺基诺隆耐药性:全面评估
Linda Kherroubi1, Joanna Bacon2, Khondaker Miraz Rahman1
1School of Cancer and Pharmaceutical Science, King's College London, London SE1 9NH, UK.
JAC-antimicrobial resistance
|August 15, 2024
概括
诺基诺抗生素面临着越来越多的细菌耐药性,这是由向酶突变和细胞膜改变所驱动的. 针对DNA回旋酶和拓聚酶IV的新型治疗方法对于对抗抗性格拉姆阴性病原体至关重要.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 自20世纪60年代以来,细菌对诺和诺抗生素的耐药性增加,对全球健康构成重大威胁.
- 世界卫生组织鉴定出了关键的格拉姆阴性病原体,如 *Klebsiella pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa* 和 *Escherichia coli*,因为它们具有广泛的耐药性.
研究的目的:
- 审查目前对诺基诺隆耐药机制的理解.
- 为了突出新型诺基诺隆耐药突变的出现.
- 强调开发新型抗微生物剂和治疗方法的必要性.
主要方法:
- 对调查诺基诺隆耐药机制的研究进行文献综述.
- 对目标酶 (DNA 陀螺酶,陀螺酶IV) 中遗传突变的分析.
- 检查波林和流出在阻力中的作用.
主要成果:
- 在DNA陀螺酶和陀螺酶IV的突变是赋予高水平诺基诺耐药性的主要机制.
- 毛孔和排水的变化也对抗性有很大的贡献.
- 新型耐药突变的出现需要开发新的治疗策略.
结论:
- 了解诺基诺耐药机制对于开发有效的治疗方法至关重要.
- 新型抗微生物药物正在开发中,其通过替代途径向DNA旋酶/拓聚酶IV.
- 为了应对抗生素耐药性日益增长的挑战,必须继续进行研究.
相关概念视频
00:57Antibiotic Selection
Overview
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...